Patients with NASH and NASH-driven hepatocellular carcinoma have also been reported to have increased hepatic StAR expression (Caballero et al., 2009; Conde de la Rosa et al., 2021). The gene discussed is STAR; the disease is metabolic dysfunction-associated steatohepatitis.